Literature DB >> 2358404

A novel carbapenem antibiotic, SM-7338 structure-activity relationships.

M Sunagawa1, H Matsumura, T Inoue, M Fukasawa, M Kato.   

Abstract

A series of new carbapenem compounds, which have a pyrrolidin-3'-ylthio group substituted with various aminocarbonyl group at C-5' position as C-2 side chain, have been prepared. The antibacterial activity and the stability to renal dehydropeptidase-I of these compounds were investigated, and the structure-activity relationships were discussed. In this series, SM-7338; (1R,5S,6S)-2-[(3S,5S)-5-dimethylaminocarbonylpyrrolidin-3-ylthi o]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid (5a) was the most interesting compound.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358404     DOI: 10.7164/antibiotics.43.519

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  5 in total

1.  In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  R Nagano; K Shibata; Y Adachi; H Imamura; T Hashizume; H Morishima
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

Review 2.  Carbapenems: past, present, and future.

Authors:  Krisztina M Papp-Wallace; Andrea Endimiani; Magdalena A Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

3.  In vitro and in vivo antibacterial activities of S-4661, a new carbapenem.

Authors:  M Tsuji; Y Ishii; A Ohno; S Miyazaki; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

4.  Synthesis of labeled meropenem for the analysis of M. tuberculosis transpeptidases.

Authors:  David B Kastrinsky; Clifton E Barry
Journal:  Tetrahedron Lett       Date:  2010       Impact factor: 2.415

5.  Determination of imipenem efflux-mediated resistance in Acinetobacter spp., using an efflux pump inhibitor.

Authors:  Ghazale Amiri; Maryam Abbasi Shaye; Masoumeh Bahreini; Asghar Mafinezhad; Kiarash Ghazvini; Mohammad Reza Sharifmoghadam
Journal:  Iran J Microbiol       Date:  2019-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.